Some other drugs selected by this assay, such as perhexiline, triamterene (Na+/K+-ATPase inhibitors), and piperlongumine (thromboxane A2 receptor antagonist), also support this prospect, since anticancer activities of cardiac glycosides (Na+/K+-ATPase inhibitors) [30] and the involvement of thromboxane A2 signaling in angiogenesis and tumor metastasis [31,32] have been reported. Here, TBXA2R is linked to neoplasm.